Insider Transactions in Q2 2024 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,968
-1.7%
|
$91,264
$23.68 P/Share
|
|
Jun 03
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,368
-1.97%
|
$54,464
$23.68 P/Share
|
|
May 25
2024
|
Kim Caple Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+39.3%
|
-
|
|
May 25
2024
|
Daniel Bradbury Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+39.39%
|
-
|
|
May 25
2024
|
Miles Harrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+39.39%
|
-
|
|
May 25
2024
|
Ellen Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+32.25%
|
-
|
|
May 25
2024
|
G Bradley Cole Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+39.39%
|
-
|
|
May 25
2024
|
Tiffany Olson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+34.49%
|
-
|
|
May 23
2024
|
Mara G. Aspinall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+16.36%
|
-
|
|
May 14
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,968
-1.65%
|
$95,232
$24.56 P/Share
|
|
May 14
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,368
-1.9%
|
$56,832
$24.56 P/Share
|
|
May 10
2024
|
Tiffany Olson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
487
+5.9%
|
-
|
|
May 06
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
23,323
-35.39%
|
$559,752
$24.64 P/Share
|
|
May 06
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,968
-3.16%
|
$95,232
$24.72 P/Share
|
|
May 06
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,368
-3.64%
|
$56,832
$24.72 P/Share
|
|
Apr 23
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
705
-0.56%
|
$14,100
$20.11 P/Share
|
|
Apr 23
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
421
-0.64%
|
$8,420
$20.11 P/Share
|
|
Apr 12
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,263
-2.51%
|
$65,260
$20.35 P/Share
|
|
Apr 12
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,947
-2.89%
|
$38,940
$20.35 P/Share
|
|
Apr 08
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
2,400
-3.5%
|
$48,000
$20.45 P/Share
|
|
Apr 05
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
11,771
-14.41%
|
$235,420
$20.86 P/Share
|
|
Apr 04
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
9,152
-9.98%
|
$192,192
$21.45 P/Share
|
|
Apr 03
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,968
-2.95%
|
$83,328
$21.7 P/Share
|
|
Apr 03
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,368
-3.4%
|
$49,728
$21.7 P/Share
|